Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
abbvie
akouos
allergan
amgen
astellas pharmaceuticals
biohaven
boston
boston blog main
california institute for biomedical research
cgpr
deals
decibel therapeutics
eli lilly
europe blog main
frequency therapeutics
harvard university
hearing loss
investing
jeffrey karp
merck
migraine
multiple sclerosis
national
national top stories
new york blog main
perceptive life sciences
regenerative medicine
robert langer
san francisco blog main
sensorineural hearing loss
taiwania capital management
the scripps research institute
What
approved
2
×
fda
medicines
2
×
treat
2
×
adults
affects
allergan
americans
class
date
developing
drug
frequency
hearing
ipo
loss
meds
migraine
millions
monday
new
nod
pill
plans
regenerative
therapeutics
treatment
ubrelvy
ubrogepant
wins
Language
unset
Current search:
treat
×
approved
×
medicines
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds